Previous 10 | Next 10 |
home / stock / biovf / biovf news
The following slide deck was published by Swedish Orphan Biovitrum AB in conjunction with their 2018 Q3 earnings Read more ...
Swedish Orphan Biovitrum AB ( OTCPK:BIOVF ): Q3 GAAP EPS of SEK2.31. More news on: Swedish Orphan Biovitrum AB, Earnings news and commentary, Healthcare stocks news, Read more ...
STOCKHOLM , Oct. 23, 2018 /PRNewswire/ -- On 31 October, at 08:00 CET , Swedish Orphan Biovitrum AB (publ) (Sobi™) will publish its report for the third quarter 2018. Financial analysts and media are invited to participate in a telephone conference, which will include a pre...
Sarepta Therapeutics (NASDAQ: SRPT ) inks an agreement with French biotech Lysogene for exclusive ex-Europe rights to gene therapy LYS-SAF302 for the potential treatment of mucopolysaccharidosis type IIIA ( MPS IIIA ), also known as Sanfilippo syndrome type A, a rare progressive disorder a...
General Overview of Pipeline Catalyst Biosciences ( CBIO ) is a clinical-stage biopharmaceutical company focused on developing hemostasis treatments. Since the company became public after a merger deal with Targacept, it is known that Catalyst has engineered three therapeutic candidates ...
As expected, the European Commission approves Ultragenyx's Mepsevii (vestronidase alfa) for the treatment of non-neurological manifestations of mucopolysaccharidosis VII (MPS VII) of Sly syndrome, a rare inherited lysosomal storage disorder. More news on: REGENXBIO, Sangamo Therapeutics,...
Swedish Orphan Biovitrum ( OTCPK:BIOVF +9% ) has completed the acquisition of the perpetual global rights to Emapalumab from Novimmune SA. More news on: Swedish Orphan Biovitrum AB, Swedish Orphan Biovitrum AB ADR, Read more ...
STOCKHOLM , August 23, 2018 /PRNewswire/ -- Following approvals from relevant competition authorities, Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO: SOBI) has completed the acquisition of the perpetual global rights to emapalumab from Novimmune SA. That Sobi had entered into a...
STOCKHOLM , Aug. 22, 2018 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) has appointed Anne Marie de Jonge Schuermans as Head of Sobi's new Technical Operations organisation, bringing together Sobi's Manufacturing Operations/Biological Development & Supply,...
News, Short Squeeze, Breakout and More Instantly...
Swedish Orphan Biovit Ord Company Name:
BIOVF Stock Symbol:
OTCMKTS Market:
WALTHAM, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced the presentation of three abstracts that highlights data from its myelofibrosis treatment option at the American Society of Clin...
WALTHAM, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation to emapalumab-lzsg being investigated as a pot...
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...